InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,319.87
(
-0.03%
)
US TECH 100
18,252.84
(
0.11%
)
Dow Jones
39,851.90
(
-0.05%
)
Brent Oil
81.65
(
-0.97%
)
Bitcoin
69,490.97
(
-0.91%
)
Post# of 251889
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 160666

Friday, 05/03/2013 2:42:23 PM

Friday, May 03, 2013 2:42:23 PM

Post# of 251889

Are you also significantly less optimistic about AGN's dual-acting (VEGF/PDGF) DARPin in preclinical development? According to yesterday's CC, the plans and timeline for this drug haven't changed at all, but this assertion might include a modicum of spin.

Of course I'll be more confidant when I see DARPin's phase IIb data, but I don't think safety was the issue, and as for efficacy the dual DARPin has theoretically a better shot to begin with, so for now I'm not less optimistic about it.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up